Psybio TherapeuticsPSYBF
13F holders, Q1 2024 (March 31)1holders
$0.01avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Psybio Therapeutics Corp. (PSYBF) in their 13F filings. The largest holder was AdvisorShares Investments LLC ($18K).
- Company
- Psybio Therapeutics Corp.
- CUSIP
- 693697104
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| AdvisorShares Investments LLC | 0.00% | No change | 2,994,817 | $18K |
"% of holder's portfolio" is PSYBF's weight in each manager's 13F, not the share of Psybio Therapeutics Corp. the manager owns.